Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation

Experimental Hematology

Volumn 32, Issue 12, 2004, Pages 1246-1254

  Cho, Seok Goo ^a   Shuto, Yukinobu ^a   Soda, Yasushi ^a   Nakazaki, Yukoh ^b   Izawa, Kiyoko ^a   Uchimaru, Kaoru ^a   Takahashi, Satoshi ^a   Tani, Kenzaburo ^a   Tojo, Arinobu ^a,c   Asano, Shigetaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Univ T   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIBODY; GANGLIOTETRAOSYLCERAMIDE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; DEPLETION; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; INJECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RADIATION DOSE; RADIOIMMUNOTHERAPY; RECIPIENT; SPLEEN; SPLEEN CELL; SURVIVAL TIME; T LYMPHOCYTE; WHOLE BODY RADIATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BONE MARROW TRANSPLANTATION; FEMALE; FLOW CYTOMETRY; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; H-2 ANTIGENS; KILLER CELLS, NATURAL; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; SPLEEN; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE; WHOLE-BODY IRRADIATION;

EID: 10044263292     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2004.08.008     Document Type: Article

References (29)

1. P.J. Henslee-Downey, S.H. Abhyankar, and R.S. Parrish Use of partially mismatched related donors extends access to allogeneic marrow transplant Blood 89 1997 3864 3872
2. M. Sykes, F. Preffer, and S. McAfee Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow Lancet 353 1999 1755 1759
3. L. Luznik, S. Jalla, L.W. Engstrom, R. Iannone, and E.J. Fuchs Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide Blood 98 2001 3456 3464
4. B.D. Johnson, and R.L. Truitt Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease Blood 85 1995 3302 3312
5. Y. Sharabi, and D.H. Sachs Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen J Exp Med 169 1989 493 502
6. T. Wekerle, J. Kurtz, and H. Ito Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host Nat Med 6 2000 464 469
7. J.L. Ferrara, J. Michaelson, S.J. Burakoff, and P. Mauch Engraftment following T cell-depleted bone marrow transplantation. III. Differential effects of increased total-body irradiation on semiallogeneic and allogeneic recipients Transplantation 45 1988 948 952
8. C. Anasetti, D. Amos, and P.G. Beatty Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma N Engl J Med 320 1989 197 204
9. R.L. Truitt, and A.A. Atasoylu Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation Blood 77 1991 2515 2523
10. W.J. Murphy, V. Kumar, and M. Bennett Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized J Exp Med 166 1987 1499 1509
11. G. Cudkowicz, and M. Bennett Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice J Exp Med 134 1971 1513 1528
12. W.J. Murphy, C.Y. Koh, A. Raziuddin, M. Bennett, and D.L. Longo Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies Immunol Rev 181 2001 279 289
13. Y.L. Colson, H. Li, S.S. Boggs, K.D. Patrene, P.C. Johnson, and S.T. Ildstad Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach J Immunol 157 1996 2820 2829
14. R. Kiessling, P.S. Hochman, O. Haller, G.M. Shearer, H. Wigzell, and G. Cudkowicz Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts Eur J Immunol 7 1977 655 663
15. G. Trinchieri Natural killer cells J.L.M. Ferrara H.J. Deeg S.J. Burakoff Graft-vs.-Host Disease 2nd ed. 1997 Marcel Dekker, Inc New York 235 255
16. J.L. Ferrara, P. Mauch, P.J. Van Dijken, K.E. Crosier, J. Michaelson, and S.J. Burakoff Evidence that anti-asialo GM1 in vivo improves engraftment of T cell-depleted bone marrow in hybrid recipients Transplantation 49 1990 134 138
17. P. Tiberghien, D.L. Longo, J.W. Wine, W.G. Alvord, and C.W. Reynolds Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery Blood 76 1990 1419 1430
18. M. Neipp, J.S. Gammie, and B.G. Exner A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment Transplantation 68 1999 369 378
19. F. Lan, D. Zeng, M. Higuchi, P. Huie, and J.P. Higgins Strober S Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells J Immunol 167 2001 2087 2096
20. K.I. Seino, K. Fukao, and K. Muramoto Requirement for natural killer T (NKT) cells in the induction of allograft tolerance Proc Natl Acad Sci U S A 98 2001 2577 2581
21. E. Lotzova, C.A. Savary, and S.B. Pollack Prevention of rejection of allogeneic bone marrow transplants by NK 1.1 antiserum Transplantation 35 1983 490 494
22. H. Chen, and W.E. Paul Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1 J Immunol 159 1997 2240 2249
23. K. Suzue, E.L. Reinherz, and S. Koyasu Critical role of NK but not NKT cells in acute rejection of parental bone marrow cells in F1 hybrid mice Eur J Immunol 31 2001 3147 3152
24. I. Scott, J. O'Shea, and M. Bunce Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selection Blood 92 1998 4864 4871
25. L.G. Lum The kinetics of immune reconstitution after human marrow transplantation Blood 69 1987 369 380
26. W.J. Murphy, M. Bennett, V. Kumar, and D.L. Longo Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation J Immunol 148 1992 2953 2960
27. G. Trinchieri Natural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis Semin Immunol 7 1995 83 88
28. C.A. Biron, K.B. Nguyen, G.C. Pien, L.P. Cousens, and T.P. Salazar-Mather Natural killer cells in antiviral defense: function and regulation by innate cytokines Annu Rev Immunol 17 1999 189 220
29. T.R. Spitzer Nonmyeloablative allogeneic stem cell transplant strategies and the role of mixed chimerism Oncologist 5 2000 215 223